This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01934/identifier/chemspider/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01934/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB01934/identifier/pubchem-compound/
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01934/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB01934/identifier/drugbank/

Statements

Subject Item
n2:DB01934
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB01934 n14:DB01934
dcterms:title
N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide
adms:identifier
n8:46509042 n9:ARY n10:46936263 n11:16743842 n12:DB01934
n5:IUPAC-Name
n6:271B5498-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B549E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B549D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B549A-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B549B-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B549C-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5496-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5494-363D-11E5-9242-09173F13E4C5 n6:271B5497-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5495-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B54A4-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B54A5-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B549F-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B54A0-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B54A2-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B54A1-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B54A3-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B54AA-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B54AC-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B54AD-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B54A9-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B54A8-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B54AB-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5499-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B54A6-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B54A7-363D-11E5-9242-09173F13E4C5